SeqLL Inc. (SQL) |
|
0.76 -0.052 (-6.38%)
|
09-24 16:36 |
|
Open: |
0.7587 |
Pre. Close: |
0.8118 |
|
High:
|
0.87 |
Low:
|
0.75 |
|
Volume:
|
12,697 |
Market Cap:
|
9(M) |
|
|
|
|
SeqLL Inc. operates as a life sciences instrumentation and research services company worldwide. The company designs, develops, and manufactures genetic analysis technologies. It offers true single molecule sequencing (tSMS) platform, which offers a single molecule solution for DNA and RNA sequencing. The company has a collaboration agreement with Bernstein Laboratory, Ting Laboratory, The Jackson Laboratory for Genomic Medicine, Weizmann Institute of Science, True Bearing Diagnostics, Inc., and Tetracore, Inc. It serves academic and government institutions, hospitals and medical centers, pharmaceutical and biotechnology companies, and non-profit research organizations. The company was founded in 2013 and is based in Billerica, Massachusetts. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
0.87 - 0.88 |
0.88 - 0.88 |
|
Low:
|
0.74 - 0.74 |
0.74 - 0.75 |
|
Close:
|
0.75 - 0.76 |
0.76 - 0.77 |
|
Technical analysis |
as of: 2022-09-23 4:27:41 PM |
|
Overall:
|
 |
| Stoxline posted a SELL today, same as yesterday. Downward movement continues. |
| Target: |
Six months: 1.07  One year: 1.2 |
| Support: |
Support1: 0.75 Support2: 0.62 |
| Resistance: |
Resistance1: 0.92 Resistance2: 1.02 |
| Pivot: |
0.88 |
| Moving Average: |
MA(5): 0.81 MA(20): 0.89
MA(100): 0.86 MA(250): 1.59 |
| MACD: |
MACD(12,26): -0.1 Signal(9): -0.1 |
| Stochastic oscillator: |
%K(14,3): 13.8 %D(3): 19.9 |
| RSI: |
RSI(14): 34.6 |
| 52-week: |
High: 5.09 Low: 0.61 |
| Average Vol(K): |
3-Month: 39 (K) 10-Days: 17 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ SQL ] has closed above bottom band by 2.3%. Bollinger Bands are 12.8% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Headline News |
Sat, 24 Sep 2022
Microsoft SQL servers hacked in TargetCompany ransomware attacks - BleepingComputer
Fri, 23 Sep 2022
Best Online Courses to Learn SQL | DatabaseJournal.com - Database Journal
Thu, 22 Sep 2022
SQL Developer at Trigger BPO - IT-Online
Tue, 20 Sep 2022
SQL Server Query Tuning and Optimization (Packt) - iProgrammer
Mon, 19 Sep 2022
Compare Azure Data Factory vs. SSIS - TechTarget
Thu, 08 Sep 2022
Microsoft offers SQL Server 2022 release candidate to Linux world - The Register
|
Financial Analysis |
| Price to Book Value: |
Outperform |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Underperform |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Neutral |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Underperform |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Outperform |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Diagnostics & Research |
| Shares Out. |
0 (M) |
| Shares Float |
12 (M) |
|
% Held by Insiders
|
4.69e+006 (%) |
|
% Held by Institutions
|
36.6 (%) |
|
Shares Short
|
24 (K) |
|
Shares Short P.Month
|
0 (K) |
Stock Financials |
|
EPS
|
-2.66e+006 |
|
EPS Est Next Qtl
|
0 |
|
EPS Est This Year
|
0 |
|
EPS Est Next Year
|
0 |
|
Book Value (p.s.)
|
0 |
|
Profit Margin (%)
|
0 |
|
Operating Margin (%)
|
-1 |
|
Return on Assets (ttm)
|
665.4 |
|
Return on Equity (ttm)
|
-32.1 |
|
Qtrly Rev. Growth
|
164530 |
|
Gross Profit (p.s.)
|
0.01 |
|
Sales Per Share
|
0.01 |
|
EBITDA (p.s.)
|
-0.14 |
|
Qtrly Earnings Growth
|
-0.4 |
|
Operating Cash Flow
|
0 (M) |
|
Levered Free Cash Flow
|
-4 (M) |
Stock Valuations |
|
PE Ratio
|
-0.01 |
|
PEG Ratio
|
0 |
|
Price to Book value
|
0 |
|
Price to Sales
|
43.03 |
|
Price to Cash Flow
|
0 |
Stock Dividends |
|
Dividend
|
0 |
|
Forward Dividend
|
34940 |
|
Dividend Yield
|
0% |
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
